A month has gone by since the last earnings report for AngioDynamics (ANGO). Shares have lost about 3.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...

Detailed price information for Angiodynamics Inc (ANGO-Q) from The Globe and Mail including charting and trades.

A downtrend has been apparent in AngioDynamics (ANGO) lately. While the stock has lost 6.1% over the past week, it could ...

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a ...

AngioDynamics, Inc.'s Q2 2025 earnings beat expectations, with non-GAAP EPS at -$0.04 and revenue at $73.02 million, driving a 35% stock surge. Med Tech division shines, with 25% revenue growth and ...

AngioDynamics, Inc. ANGO reported breakeven adjusted earnings per share for second-quarter fiscal 2026, marking an improvement from the year-ago quarter’s adjusted loss of 4 cents. The Zacks Consensus ...

AngioDynamics, Inc. posted mixed results in its FY'23 reports, with strong growth in its Med Tech division. The company's focus going forward will be on its Med Tech segment, which has shown high ...

Shares of AngioDynamics, Inc. (NASDAQ:ANGO) are up Thursday after the biotechnology company raised guidance for four key financial metrics and shared positive sales performance for this past quarter.